Efficacy and safety of a pressurized metered-dose inhaler in older asthmatics: Comparison to a dry powder inhaler in a 12-week randomized trial

Allergy, Asthma and Immunology Research

Volumn 12, Issue 3, 2020, Pages 454-466

  Woo, Seong Dae ^a   Ye, Young Min ^a   Lee, Youngsoo ^a   Lee, So Hee ^a   Shin, Yoo Seob ^a   Park, Joo Hun ^a   Choi, Hyunna ^b   Lee, Hyun Young ^b   Shin, Hyun Jung ^b   Park, Hae Sim ^a  

^a Ajou University School of Medicine   (South Korea)

^b Ajou University Medical CentSuwon   (South Korea)

Author keywords

Aged; Airway management; Asthma; Dry powder inhalers; Medication adherence; Metered dose inhalers

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; FLUTICASONE PROPIONATE PLUS FORMOTEROL FUMARATE; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; LONG ACTING DRUG; METHACHOLINE;

AGED; ARTICLE; ASTHMA; BRONCHITIS; COMBINATION DRUG THERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CONTROL; DISEASE DURATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; LARYNX DISORDER; LOW DRUG DOSE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NON-INFERIORITY TRIAL; OPEN STUDY; PARALLEL DESIGN; PATIENT COMPLIANCE; PATIENT SAFETY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RHINOPHARYNGITIS; SIDE EFFECT; SORE THROAT; THRUSH; VOICE CHANGE;

EID: 85088283506     PISSN: 20927355     EISSN: 20927363     Source Type: Journal    
DOI: 10.4168/aair.2020.12.3.454     Document Type: Article

References (35)

1. Gibson PG, McDonald VM, Marks GB. Asthma in older adults. Lancet 2010; 376:803-13. PUBMED | CROSSREF
2. Song WJ, Cho SH. Challenges in the management of asthma in the elderly. Allergy Asthma Immunol Res 2015; 7:431-9. PUBMED | CROSSREF
3. Niewoehner DE, Kleinerman J. Morphologic basis of pulmonary resistance in the human lung and effects of aging. J Appl Physiol 1974; 36:412-8. PUBMED | CROSSREF
4. Milic-Emili J, Torchio R, D'Angelo E. Closing volume: A reappraisal (1967-2007). Eur J Appl Physiol 2007; 99:567-83. PUBMED | CROSSREF
5. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999; 13:197-205. PUBMED | CROSSREF
6. Zein JG, Dweik RA, Comhair SA, Bleecker ER, Moore WC, Peters SP, et al. Asthma is more severe in older adults. PLoS One 2015; 10:e0133490. PUBMED | CROSSREF
7. Haughney J, Price D, Barnes NC, Virchow JC, Roche N, Chrystyn H. Choosing inhaler devices for people with asthma: Current knowledge and outstanding research needs. Respir Med 2010; 104:1237-45. PUBMED | CROSSREF
8. Virchow JC, Crompton GK, Dal Negro R, Pedersen S, Magnan A, Seidenberg J, et al. Importance of inhaler devices in the management of airway disease. Respir Med 2008; 102:10-9. PUBMED | CROSSREF
9. Ahookhosh K, Yaqoubi S, Mohammadpourfard M, Hamishehkar H, Aminfar H. Experimental investigation of aerosol deposition through a realistic respiratory airway replica: An evaluation for MDI and DPI performance. Int J Pharm 2019; 566:157-72. PUBMED | CROSSREF
10. De Backer W, Devolder A, Poli G, Acerbi D, Monno R, Herpich C, et al. Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients. J Aerosol Med Pulm Drug Deliv 2010; 23:137-48. PUBMED | CROSSREF
11. Longest PW, Tian G, Walenga RL, Hindle M. Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways. Pharm Res 2012; 29:1670-88. PUBMED | CROSSREF
12. Usmani OS. Small airways dysfunction in asthma: Evaluation and management to improve asthma control. Allergy Asthma Immunol Res 2014; 6:376-88. PUBMED | CROSSREF
13. Price DB, Román-Rodríguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, et al. Inhaler errors in the CRITIKAL study: Type, frequency, and association with asthma outcomes. J Allergy Clin Immunol Pract 2017; 5:1071-1081.e9. PUBMED | CROSSREF
14. Al-Jahdali H, Ahmed A, Al-Harbi A, Khan M, Baharoon S, Bin Salih S, et al. Improper inhaler technique is associated with poor asthma control and frequent emergency department visits. Allergy Asthma Clin Immunol 2013; 9:8. PUBMED | CROSSREF
15. Newman SP, Weisz AW, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991; 46:712-6. PUBMED | CROSSREF
16. Tashkin DP. New devices for asthma. J Allergy Clin Immunol 1998; 101:S409-16. PUBMED | CROSSREF
17. Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005; 127:335-71. PUBMED | CROSSREF
18. Global Initiative for Asthma. Global strategy for asthma management and prevention 2015 [Internet]. [place unknown]: Global Initiative for Asthma; 2015 [cited 2015 Dec]. Available from: http://www.ginasthma.org.
19. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med 1994; 149:S69-76. PUBMED | CROSSREF
20. Huitfeldt B, Hummel J; European Federation of Statisticians in the Pharmaceutical Industry (EFSPI). The draft FDA guideline on non-inferiority clinical trials: A critical review from European pharmaceutical industry statisticians. Pharm Stat 2011; 10:414-9. PUBMED | CROSSREF
21. Müller V, Gálffy G, Eszes N, Losonczy G, Bizzi A, Nicolini G, et al. Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulm Med 2011; 11:40. PUBMED | CROSSREF
22. Price D, Small I, Haughney J, Ryan D, Gruffydd-Jones K, Lavorini F, et al. Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: A retrospective matched observational study of real-world patients. Prim Care Respir J 2013; 22:439-48. PUBMED | CROSSREF
23. Rhee CK, van Boven JF, Yau Ming SW, Park HY, Kim DK, Park HS, et al. Does changing inhaler device impact real-life asthma outcomes? Clinical and economic evaluation. J Allergy Clin Immunol Pract 2019; 7:934-42. PUBMED | CROSSREF
24. Bodzenta-Lukaszyk A, Buhl R, Balint B, Lomax M, Spooner K, Dissanayake S. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: A randomized, controlled, non-inferiority trial of efficacy and safety. J Asthma 2012; 49:1060-70. PUBMED | CROSSREF
25. Kim MH, Kim SH, Park SY, Ban GY, Kim JH, Jung JW, et al. Characteristics of adult severe refractory asthma in korea analyzed from the severe asthma registry. Allergy Asthma Immunol Res 2019; 11:43-54. PUBMED | CROSSREF
26. Postma DS, Brightling C, Baldi S, Van den Berge M, Fabbri LM, Gagnatelli A, et al. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): Baseline data from a prospective cohort study. Lancet Respir Med 2019; 7:402-16. PUBMED | CROSSREF
27. Contoli M, Kraft M, Hamid Q, Bousquet J, Rabe KF, Fabbri LM, et al. Do small airway abnormalities characterize asthma phenotypes? In search of proof. Clin Exp Allergy 2012; 42:1150-60. PUBMED | CROSSREF
28. Ulambayar B, Lee SH, Yang EM, Ye YM, Park HS. Association between epithelial cytokines and clinical phenotypes of elderly asthma. Allergy Asthma Immunol Res 2019; 11:79-89. PUBMED | CROSSREF
29. Contoli M, Baraldo S, Marku B, Casolari P, Marwick JA, Turato G, et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. J Allergy Clin Immunol 2010; 125:830-7. PUBMED | CROSSREF
30. Martinez CH, Diaz AA, Meldrum C, Curtis JL, Cooper CB, Pirozzi C, et al. Age and small airway imaging abnormalities in subjects with and without airflow obstruction in SPIROMICS. Am J Respir Crit Care Med 2017; 195:464-72. PUBMED | CROSSREF
31. Cassino C, Berger KI, Goldring RM, Norman RG, Kammerman S, Ciotoli C, et al. Duration of asthma and physiologic outcomes in elderly nonsmokers. Am J Respir Crit Care Med 2000; 162:1423-8. PUBMED | CROSSREF
32. Crane MA, Jenkins CR, Goeman DP, Douglass JA. Inhaler device technique can be improved in older adults through tailored education: Findings from a randomised controlled trial. NPJ Prim Care Respir Med 2014; 24:14034. PUBMED | CROSSREF
33. Lurslurchachai L, Krauskopf K, Roy A, Halm EA, Leventhal H, Wisnivesky JP. Metered dose inhaler technique among inner-city asthmatics and its association with asthma medication adherence. Clin Respir J 2014; 8:397-403. PUBMED | CROSSREF
34. Geller DE. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Respir Care 2005; 50:1313-21. PUBMED
35. Roland NJ, Bhalla RK, Earis J. The local side effects of inhaled corticosteroids: Current understanding and review of the literature. Chest 2004; 126:213-9. PUBMED | CROSSREF